ScholarIQanswers from OpenAlex

Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer

PaperCitations, authors & open-access status

Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer have?

ScholarIQcitation count

Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer has 330 citations in the OpenAlex counts ScholarIQ stores.

When was Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer published?

ScholarIQyear

Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer has 2015 year in the ScholarIQ index.

What is the open-access status of Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer?

ScholarIQoa status

Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer has closed oa status in the ScholarIQ index.

What is the DOI of Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer?

ScholarIQdoi

The DOI for Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer is on the source record.

What is the PMID of Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer?

ScholarIQpmid

The PMID for Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer is on the source record.

What is the OpenAlex record for Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer?

ScholarIQopenalex

The OpenAlex for Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial